[
  {
    "model": "dashboard.facilitytest",
    "pk": 1,
    "fields": {
      "order": 1,
      "name": "Facility Reporting",
      "created": "2017-11-27T08:15:31.589Z",
      "last_updated": "2018-04-05T03:58:15.648Z",
      "definition": "{\"type\": {\"id\": \"ClassBased\", \"name\": \"Class Based Facility Check\"}, \"python_class\": \"dashboard.checks.legacy.blanks.IsReportingCheck\"}",
      "description": "Reports if the facility has submitted an order or not during a given cycle",
      "short_description": "Did the facility submit an order?",
      "featured": true,
      "slug": "facility-reporting"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 2,
    "fields": {
      "order": 2,
      "name": "GUIDELINE ADHERENCE (Adult 1L)",
      "created": "2017-11-27T08:15:31.590Z",
      "last_updated": "2018-04-06T15:33:36.339Z",
      "definition": "{\r\n  \"operator\": {\r\n    \"id\": \"AtLeastNOfTotal\",\r\n    \"name\": \"LessThan\"\r\n  },\r\n  \"operatorConstant\": 90,\r\n  \"type\": {\r\n    \"id\": \"FacilityTwoGroups\",\r\n    \"name\": \"Facility with 2 Groups of data\",\r\n    \"comparisons\": [\r\n      {\r\n        \"id\": \"LessThan\",\r\n        \"name\": \"Percentage Variance is less than\"\r\n      },\r\n      {\r\n        \"id\": \"AtLeastNOfTotal\",\r\n        \"name\": \"Group1 Is at least N% of the total\"\r\n      },\r\n      {\r\n        \"id\": \"AreEqual\",\r\n        \"name\": \"Are Equal\"\r\n      },\r\n      {\r\n        \"id\": \"AreNotEqual\",\r\n        \"name\": \"Are Not Equal\"\r\n      },\r\n      {\r\n        \"id\": \"NoNegatives\",\r\n        \"name\": \"Has No Negatives\"\r\n      },\r\n      {\r\n        \"id\": \"NoBlanks\",\r\n        \"name\": \"Has No Blanks\"\r\n      }\r\n    ],\r\n    \"calculations\": [\r\n      {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"Sum\"\r\n      },\r\n      {\r\n        \"id\": \"AVG\",\r\n        \"name\": \"Average\"\r\n      },\r\n      {\r\n        \"id\": \"VALUE\",\r\n        \"name\": \"Values\"\r\n      }\r\n    ],\r\n    \"models\": [\r\n      {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": false\r\n      },\r\n      {\r\n        \"id\": \"Paed\",\r\n        \"name\": \"Paed Records\",\r\n        \"selectId\": \"FacilityTwoGroupsPaed\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/EFV\",\r\n          \"ABC/3TC/LPV/r\",\r\n          \"ABC/3TC/NVP\",\r\n          \"AZT/3TC/ABC\",\r\n          \"AZT/3TC/EFV\",\r\n          \"AZT/3TC/LPV/r\",\r\n          \"AZT/3TC/NVP\"\r\n        ],\r\n        \"hasTrace\": false\r\n      },\r\n      {\r\n        \"id\": \"Consumption\",\r\n        \"name\": \"Consumption Records\",\r\n        \"selectId\": \"FacilityTwoGroupsConsumption\",\r\n        \"fields\": [\r\n          \"closing_balance\",\r\n          \"consumption\",\r\n          \"days_out_of_stock\",\r\n          \"estimated_number_of_new_patients\",\r\n          \"estimated_number_of_new_pregnant_women\",\r\n          \"loses_adjustments\",\r\n          \"months_of_stock_on_hand\",\r\n          \"opening_balance\",\r\n          \"packs_ordered\",\r\n          \"quantity_received\",\r\n          \"quantity_required_for_current_patients\"\r\n        ],\r\n        \"formulations\": [\r\n          \"Abacavir (ABC) 300mg\",\r\n          \"Abacavir (ABC) 60mg\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 600mg/300mg [Pack 30]\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Atazanavir/Ritonavir (ATV/r) 300mg/100mg [Pack 30]\",\r\n          \"Cotrimoxazole 120mg [Pack 1000]\",\r\n          \"Cotrimoxazole 960mg[Pack 1000]\",\r\n          \"Dapsone 100mg [Pack 1000]\",\r\n          \"Efavirenz (EFV) 200mg [Pack 90]\",\r\n          \"Efavirenz (EFV) 50mg [Pack 60]\",\r\n          \"Efavirenz (EFV) 600mg [Pack 30]\",\r\n          \"Fluconazole (FL) 200mg [Pack 28]\",\r\n          \"Fluconazole (FL) IV [IV 100ml]\",\r\n          \"Fluconazole (FL) oral solution [Bottle 35ml]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 100mg/25mg\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 200mg/50mg [Pack 120]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 40mg/10mg Pellets [Pack of 120]\",\r\n          \"Nevirapine (NVP) 10mg/ml oral susp.[Bottle 1000ml]\",\r\n          \"Nevirapine (NVP) 200mg [Pack 60]\",\r\n          \"Nevirapine (NVP) 50mg [Pack 60]\",\r\n          \"Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg [Pack 30]\",\r\n          \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\",\r\n          \"Zidovudine (AZT) 300mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 300mg/150mg/200mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 60mg/30mg/50mg [Pack 60]\"\r\n        ],\r\n        \"hasTrace\": false\r\n      }\r\n    ]\r\n  },\r\n  \"groups\": [\r\n    {\r\n      \"selected_formulations\": [\r\n        \"TDF/3TC/EFV (PMTCT)\",\r\n        \"TDF/3TC/EFV (ADULT)\"\r\n      ],\r\n      \"name\": \"G1\",\r\n      \"selected_fields\": [\r\n        \"new\"\r\n      ],\r\n      \"aggregation\": {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"SUM\"\r\n      },\r\n      \"model\": {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": false\r\n      },\r\n      \"cycle\": {\r\n        \"id\": \"Current\",\r\n        \"name\": \"Current Cycle\"\r\n      },\r\n      \"cycles\": [\r\n        {\r\n          \"id\": \"Current\",\r\n          \"name\": \"Current Cycle\"\r\n        }\r\n      ]\r\n    },\r\n    {\r\n      \"selected_formulations\": [\r\n        \"ABC/3TC/AZT (ADULT)\",\r\n        \"ABC/3TC/AZT (PMTCT)\",\r\n        \"ABC/3TC/EFV (ADULT)\",\r\n        \"ABC/3TC/EFV (PMTCT)\",\r\n        \"ABC/3TC/NVP (ADULT)\",\r\n        \"ABC/3TC/NVP (PMTCT)\",\r\n        \"AZT/3TC/EFV (ADULT)\",\r\n        \"AZT/3TC/EFV (PMTCT)\",\r\n        \"AZT/3TC/NVP (ADULT)\",\r\n        \"AZT/3TC/NVP (PMTCT)\",\r\n        \"TDF/3TC/AZT (ADULT)\",\r\n        \"TDF/3TC/AZT (PMTCT)\"\r\n      ],\r\n      \"name\": \"G2\",\r\n      \"selected_fields\": [\r\n        \"new\"\r\n      ],\r\n      \"aggregation\": {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"SUM\"\r\n      },\r\n      \"model\": {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": false\r\n      },\r\n      \"cycle\": {\r\n        \"id\": \"Current\",\r\n        \"name\": \"Current Cycle\"\r\n      },\r\n      \"cycles\": [\r\n        {\r\n          \"id\": \"Current\",\r\n          \"name\": \"Current Cycle\"\r\n        },\r\n        {\r\n          \"id\": \"Previous\",\r\n          \"name\": \"Previous Cycle\"\r\n        }\r\n      ]\r\n    }\r\n  ]\r\n}",
      "description": "Tests if the facility is adhering to national guidelines for Adult 1st Line therapy.\r\n\r\nThis is done by testing if the volume of new ART patients on Adult TDF/3TC/EFV 300/300/600mg formulation represent at least 90% of the total of those on Adult 1L  formulations (all currently available Adult 1L regimens)",
      "short_description": "GUIDELINE ADHERENCE (Adult 1L): New patients on TDF/3TC/EFV 300/300/600mg formulation is 90%+ of total new patients in period?",
      "featured": true,
      "slug": "guideline-adherence-adult-1-l"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 3,
    "fields": {
      "order": 3,
      "name": "GUIDELINE ADHERENCE (Adult 2L)",
      "created": "2017-11-27T08:15:31.591Z",
      "last_updated": "2018-04-05T03:58:15.650Z",
      "definition": "{\"operator\": {\"id\": \"AtLeastNOfTotal\", \"name\": \"LessThan\"}, \"operatorConstant\": 80, \"type\": {\"id\": \"FacilityTwoGroups\"}, \"groups\": [{\"selected_formulations\": [\"ABC/3TC/ATV/r (ADULT)\", \"ABC/3TC/ATV/r (PMTCT)\", \"AZT/3TC/ATV/r (ADULT)\", \"AZT/3TC/ATV/r (PMTCT)\", \"TDF/3TC/ATV/r (ADULT)\", \"TDF/3TC/ATV/r (PMTCT)\"], \"name\": \"G1\", \"selected_fields\": [\"new\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"model\": {\"id\": \"Adult\", \"name\": \"Adult Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [\"ABC/3TC/LPV/r (ADULT)\", \"ABC/3TC/LPV/r (PMTCT)\", \"AZT/3TC/LPV/r (ADULT)\", \"AZT/3TC/LPV/r (PMTCT)\", \"TDF/3TC/LPV/r (ADULT)\", \"TDF/3TC/LPV/r (PMTCT)\"], \"name\": \"G2\", \"selected_fields\": [\"new\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"model\": {\"id\": \"Adult\", \"name\": \"Adult Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}]}",
      "description": "Tests if the facility is adhering to national guidelines for Adult 2nd Line therapy\r\n\r\nThis is done by testing if the volume of new ART patients on Adult ATV/r-based formulations (i.e. ATV/r 300/100mg) represent at least 80% of the total of those on ATV/r-based and LPV/r-based formulations (Adult LPV/r-based formulations are LPV/r 200/50mg)",
      "short_description": "GUIDELINE ADHERENCE (Adult 2L): New patients on ATV/r-based formulations are 80%+ of total new patients for the period?",
      "featured": false,
      "slug": "guideline-adherence-adult-2-l"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 4,
    "fields": {
      "order": 4,
      "name": "GUIDELINE ADHERENCE (Paediatric 1L)",
      "created": "2017-11-27T08:15:31.591Z",
      "last_updated": "2018-04-05T03:58:15.651Z",
      "definition": "{\"operator\": {\"id\": \"AtLeastNOfTotal\", \"name\": \"LessThan\"}, \"operatorConstant\": 80, \"type\": {\"id\": \"FacilityTwoGroups\"}, \"groups\": [{\"selected_formulations\": [\"ABC/3TC/EFV\", \"ABC/3TC/NVP\", \"ABC/3TC/LPV/r\"], \"name\": \"G1\", \"selected_fields\": [\"new\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"model\": {\"id\": \"Paed\", \"name\": \"Paed Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [\"AZT/3TC/ABC\", \"AZT/3TC/EFV\", \"AZT/3TC/LPV/r\", \"AZT/3TC/NVP\"], \"name\": \"G2\", \"selected_fields\": [\"new\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"model\": {\"id\": \"Paed\", \"name\": \"Paed Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}]}",
      "description": "Tests if the facility is adhering to national guidelines for Paediatric 1st Line therapy\r\n\r\nThis is done by testing if the volume of new Paediatric ART patients on Paediatric ABC-based formulations (i.e. ABC/3TC 120/60mg) represent at least 80% of the total of those on ABC-based and AZT-based formulations (Paediatric AZT-based formulations including AZT/3TC 60/30mg)",
      "short_description": "GUIDELINE ADHERENCE (Paediatric 1L): New Paediatric ART patients on ABC-based formulations are 80%+ of total new Paediatric patients in the period?",
      "featured": false,
      "slug": "guideline-adherence-paediatric-1-l"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 5,
    "fields": {
      "order": 15,
      "name": "MULTIPLE ORDERS",
      "created": "2017-11-27T08:15:31.592Z",
      "last_updated": "2018-04-05T03:58:15.661Z",
      "definition": "{\"type\": {\"id\": \"ClassBased\", \"name\": \"Class Based Facility Check\"}, \"python_class\": \"dashboard.checks.legacy.blanks.MultipleCheck\"}",
      "description": "Reports facilities that have submitted more than one order during a given cycle",
      "short_description": "MULTIPLE ORDERS: Submitted more than one order?",
      "featured": false,
      "slug": "multiple-orders"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 6,
    "fields": {
      "order": 5,
      "name": "NO BLANKS",
      "created": "2017-11-27T08:15:31.592Z",
      "last_updated": "2018-04-07T23:44:47.299Z",
      "definition": "{\r\n  \"operator\": {\r\n    \"id\": \"NoBlanks\",\r\n    \"name\": \"NoBlanks\"\r\n  },\r\n  \"type\": {\r\n    \"id\": \"FacilityTwoGroupsAndTracingFormulation\",\r\n    \"name\": \"Facility with 2 Groups And Tracing Formulation\",\r\n    \"comparisons\": [\r\n      {\r\n        \"id\": \"LessThan\",\r\n        \"name\": \"Percentage Variance is less than\"\r\n      },\r\n      {\r\n        \"id\": \"AtLeastNOfTotal\",\r\n        \"name\": \"Group1 Is at least N% of the total\"\r\n      },\r\n      {\r\n        \"id\": \"AreEqual\",\r\n        \"name\": \"Are Equal\"\r\n      },\r\n      {\r\n        \"id\": \"AreNotEqual\",\r\n        \"name\": \"Are Not Equal\"\r\n      },\r\n      {\r\n        \"id\": \"NoNegatives\",\r\n        \"name\": \"Has No Negatives\"\r\n      },\r\n      {\r\n        \"id\": \"NoBlanks\",\r\n        \"name\": \"Has No Blanks\"\r\n      }\r\n    ],\r\n    \"calculations\": [\r\n      {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"Sum\"\r\n      },\r\n      {\r\n        \"id\": \"AVG\",\r\n        \"name\": \"Average\"\r\n      },\r\n      {\r\n        \"id\": \"VALUE\",\r\n        \"name\": \"Values\"\r\n      }\r\n    ],\r\n    \"models\": [\r\n      {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": true,\r\n        \"overrideOptions\": []\r\n      },\r\n      {\r\n        \"id\": \"Paed\",\r\n        \"name\": \"Paed Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationPaed\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/EFV\",\r\n          \"ABC/3TC/LPV/r\",\r\n          \"ABC/3TC/NVP\",\r\n          \"AZT/3TC/ABC\",\r\n          \"AZT/3TC/EFV\",\r\n          \"AZT/3TC/LPV/r\",\r\n          \"AZT/3TC/NVP\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": true,\r\n        \"overrideOptions\": []\r\n      },\r\n      {\r\n        \"id\": \"Consumption\",\r\n        \"name\": \"Consumption Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationConsumption\",\r\n        \"fields\": [\r\n          \"closing_balance\",\r\n          \"consumption\",\r\n          \"days_out_of_stock\",\r\n          \"estimated_number_of_new_patients\",\r\n          \"estimated_number_of_new_pregnant_women\",\r\n          \"loses_adjustments\",\r\n          \"months_of_stock_on_hand\",\r\n          \"opening_balance\",\r\n          \"packs_ordered\",\r\n          \"quantity_received\",\r\n          \"quantity_required_for_current_patients\"\r\n        ],\r\n        \"formulations\": [\r\n          \"Abacavir (ABC) 300mg\",\r\n          \"Abacavir (ABC) 60mg\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 600mg/300mg [Pack 30]\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Atazanavir/Ritonavir (ATV/r) 300mg/100mg [Pack 30]\",\r\n          \"Cotrimoxazole 120mg [Pack 1000]\",\r\n          \"Cotrimoxazole 960mg[Pack 1000]\",\r\n          \"Dapsone 100mg [Pack 1000]\",\r\n          \"Efavirenz (EFV) 200mg [Pack 90]\",\r\n          \"Efavirenz (EFV) 50mg [Pack 60]\",\r\n          \"Efavirenz (EFV) 600mg [Pack 30]\",\r\n          \"Fluconazole (FL) 200mg [Pack 28]\",\r\n          \"Fluconazole (FL) IV [IV 100ml]\",\r\n          \"Fluconazole (FL) oral solution [Bottle 35ml]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 100mg/25mg\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 200mg/50mg [Pack 120]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 40mg/10mg Pellets [Pack of 120]\",\r\n          \"Nevirapine (NVP) 10mg/ml oral susp.[Bottle 1000ml]\",\r\n          \"Nevirapine (NVP) 200mg [Pack 60]\",\r\n          \"Nevirapine (NVP) 50mg [Pack 60]\",\r\n          \"Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg [Pack 30]\",\r\n          \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\",\r\n          \"Zidovudine (AZT) 300mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 300mg/150mg/200mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 60mg/30mg/50mg [Pack 60]\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": false,\r\n        \"overrideOptions\": []\r\n      }\r\n    ]\r\n  },\r\n  \"groups\": [\r\n    {\r\n      \"cycles\": [\r\n        {\r\n          \"id\": \"Current\",\r\n          \"name\": \"Current Cycle\"\r\n        }\r\n      ],\r\n      \"cycle\": {\r\n        \"id\": \"Current\",\r\n        \"name\": \"Current Cycle\"\r\n      },\r\n      \"model\": {\r\n        \"id\": \"Consumption\",\r\n        \"name\": \"Consumption Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationConsumption\",\r\n        \"fields\": [\r\n          \"closing_balance\",\r\n          \"consumption\",\r\n          \"days_out_of_stock\",\r\n          \"estimated_number_of_new_patients\",\r\n          \"estimated_number_of_new_pregnant_women\",\r\n          \"loses_adjustments\",\r\n          \"months_of_stock_on_hand\",\r\n          \"opening_balance\",\r\n          \"packs_ordered\",\r\n          \"quantity_received\",\r\n          \"quantity_required_for_current_patients\"\r\n        ],\r\n        \"formulations\": [\r\n          \"Abacavir (ABC) 300mg\",\r\n          \"Abacavir (ABC) 60mg\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 600mg/300mg [Pack 30]\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Atazanavir/Ritonavir (ATV/r) 300mg/100mg [Pack 30]\",\r\n          \"Cotrimoxazole 120mg [Pack 1000]\",\r\n          \"Cotrimoxazole 960mg[Pack 1000]\",\r\n          \"Dapsone 100mg [Pack 1000]\",\r\n          \"Efavirenz (EFV) 200mg [Pack 90]\",\r\n          \"Efavirenz (EFV) 50mg [Pack 60]\",\r\n          \"Efavirenz (EFV) 600mg [Pack 30]\",\r\n          \"Fluconazole (FL) 200mg [Pack 28]\",\r\n          \"Fluconazole (FL) IV [IV 100ml]\",\r\n          \"Fluconazole (FL) oral solution [Bottle 35ml]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 100mg/25mg\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 200mg/50mg [Pack 120]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 40mg/10mg Pellets [Pack of 120]\",\r\n          \"Nevirapine (NVP) 10mg/ml oral susp.[Bottle 1000ml]\",\r\n          \"Nevirapine (NVP) 200mg [Pack 60]\",\r\n          \"Nevirapine (NVP) 50mg [Pack 60]\",\r\n          \"Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg [Pack 30]\",\r\n          \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\",\r\n          \"Zidovudine (AZT) 300mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 300mg/150mg/200mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 60mg/30mg/50mg [Pack 60]\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": false,\r\n        \"overrideOptions\": []\r\n      },\r\n      \"aggregation\": {\r\n        \"id\": \"VALUE\",\r\n        \"name\": \"Values\"\r\n      },\r\n      \"selected_fields\": [\r\n        \"opening_balance\",\r\n        \"closing_balance\",\r\n        \"loses_adjustments\",\r\n        \"quantity_received\",\r\n        \"consumption\"\r\n      ],\r\n      \"selected_formulations\": [],\r\n      \"sample_formulation_model_overridden\": {},\r\n      \"sample_formulation_model_overrides\": {},\r\n      \"name\": \"G1\",\r\n      \"has_thresholds\": false\r\n    }\r\n  ]\r\n}",
      "description": "Tests if the facility has submitted a complete order form or has left blanks in any data fields where a number (either zero or otherwise) should have been input. The following columns should not be left blank: Opening Balance, Quantity Received, ART & eMTCT Consumption, Losses / Adjustments, Days Out of Stock, Closing Balance.",
      "short_description": "NO BLANKS: Order form free of blanks?",
      "featured": false,
      "slug": "no-blanks"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 7,
    "fields": {
      "order": 7,
      "name": "NO NEGATIVES",
      "created": "2017-11-27T08:15:31.593Z",
      "last_updated": "2018-04-05T03:58:15.654Z",
      "definition": "{\"operator\": {\"id\": \"NoNegatives\", \"name\": \"NoNegatives\"}, \"type\": {\"id\": \"FacilityTwoGroupsAndTracingFormulation\"}, \"groups\": [{\"selected_formulations\": [], \"name\": \"G1\", \"selected_fields\": [\"opening_balance\", \"consumption\", \"closing_balance\", \"estimated_number_of_new_patients\", \"quantity_received\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}]}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the facility has input a negative number into any of four key data fields (Opening Balance, Quantity Received, ART Consumption, Closing Balance and Estimated New ART Patients) where a positive number or zero should be",
      "short_description": "NO NEGATIVES: Order free of negative inputs?",
      "featured": false,
      "slug": "no-negatives"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 8,
    "fields": {
      "order": 6,
      "name": "VOLUME TALLY",
      "created": "2017-11-27T08:15:31.593Z",
      "last_updated": "2018-04-05T03:58:15.653Z",
      "definition": "{\"operator\": {\"id\": \"LessThan\", \"name\": \"Percentage Variance is less than\"}, \"operatorConstant\": 30, \"type\": {\"id\": \"FacilityTwoGroupsAndTracingFormulation\"}, \"groups\": [{\"selected_formulations\": [], \"name\": \"Patients in Current Cycle\", \"factors\": {\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\": 0.5, \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\": 0.2173913043478261, \"Efavirenz (EFV) 200mg [Pack 90]\": 1}, \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_factors\": true, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [], \"name\": \"G2\", \"selected_fields\": [\"new\", \"existing\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"sample_formulation_model_overrides\": {\"abc3tc-paed\": {\"formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"id\": \"Paed\"}, \"efv200-paed\": {\"formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"id\": \"Paed\"}}, \"model\": {\"hasTrace\": true, \"id\": \"Adult\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Adult Records\"}, \"sample_formulation_model_overridden\": {\"abc3tc-paed\": true, \"efv200-paed\": true}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}]}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the facility has reported corresponding Consumption volumes and Patient numbers that \"make sense\", i.e. are within 30% of each other. The specific datapoints compared are:\r\n\r\n1) For Sample Formulation 1, Adult TDF/3TC/EFV: Compares bimonthly Consumption volumes of formulation Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30] (converted into an estimated Patients figure by dividing by 2.0) with Patient Numbers for regimens TDF/3TC/EFV (ADULT) and TDF/3TC/EFV (PMTCT)\r\n\r\n2) For Sample Formulation 2, Paediatric ABC/3TC: Compares bimonthly Consumption volumes of formulation Abacavir/Lamivudine (ABC/3TC) 120mg/60mg [Pack 60] (converted into an estimated Patients figure by dividing by 4.6) with Patient Numbers for regimens ABC/3TC/EFV (PAED), ABC/3TC/NVP (PAED) and ABC/3TC/LPV/r (PAED)\r\n\r\n3) For Sample Formulation 3, Paediatric EFV: Compares bimonthly Consumption volumes of formulation Efavirenz (EFV) 200mg [Pack 90] (converted into an estimated Patients figure by dividing by 1.0) with Patient Numbers for regimens ABC/3TC/EFV (PAED) and AZT/3TC/EFV (PAED)",
      "short_description": "VOLUME TALLY: Consumption and patient volumes within 30%?",
      "featured": false,
      "slug": "volume-tally"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 9,
    "fields": {
      "order": 8,
      "name": "NON-REPEATING",
      "created": "2017-11-27T08:15:31.594Z",
      "last_updated": "2018-04-05T03:58:15.655Z",
      "definition": "{\"operator\": {\"id\": \"AreNotEqual\", \"name\": \"AreNotEqual\"}, \"type\": {\"id\": \"FacilityTwoGroupsAndTracingFormulation\"}, \"groups\": [{\"selected_formulations\": [], \"name\": \"G0\", \"selected_fields\": [\"consumption\", \"opening_balance\", \"days_out_of_stock\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [], \"name\": \"G1\", \"selected_fields\": [\"consumption\", \"opening_balance\", \"days_out_of_stock\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Previous\", \"name\": \"Previous Cycle\"}}]}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the facility has submitted the same order in consecutive cycles. This is done by comparing certain key datapoints (Opening Balance, ART Consumption, Days Out of Stock) from a given cycle with the same datapoints reported in the previous cycle",
      "short_description": "NON-REPEATING: Order changes in consecutive cycles?",
      "featured": false,
      "slug": "non-repeating"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 10,
    "fields": {
      "order": 9,
      "name": "OPENING = CLOSING",
      "created": "2017-11-27T08:15:31.595Z",
      "last_updated": "2018-04-05T03:58:15.656Z",
      "definition": "{\"operator\": {\"id\": \"AreEqual\", \"name\": \"AreEqual\"}, \"type\": {\"id\": \"FacilityTwoGroupsAndTracingFormulation\"}, \"groups\": [{\"selected_formulations\": [], \"name\": \"G1\", \"selected_fields\": [\"opening_balance\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [], \"name\": \"G2\", \"selected_fields\": [\"closing_balance\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Previous\", \"name\": \"Previous Cycle\"}}]}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the \"Opening Balance\" reported by the facility in one cycle is the same as the \"Closing Balance\" result of the previous cycle",
      "short_description": "OPENING = CLOSING: Opening  balance = Closing balance from previous cycle?",
      "featured": false,
      "slug": "opening-closing"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 11,
    "fields": {
      "order": 10,
      "name": "STABLE CONSUMPTION",
      "created": "2017-11-27T08:15:31.595Z",
      "last_updated": "2018-04-05T03:58:15.657Z",
      "definition": "{\"operator\": {\"id\": \"LessThan\", \"name\": \"Percentage Variance is less than\"}, \"operatorConstant\": 50, \"type\": {\"id\": \"FacilityTwoGroupsAndTracingFormulation\"}, \"groups\": [{\"selected_formulations\": [], \"name\": \"G1\", \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_thresholds\": true, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"thresholds\": {\"abc3tc-paed\": 10, \"efv200-paed\": 10, \"tdf3tcefv-adult\": 20}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [], \"name\": \"G2\", \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_thresholds\": true, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"thresholds\": {\"abc3tc-paed\": 10, \"efv200-paed\": 10, \"tdf3tcefv-adult\": 20}, \"cycle\": {\"id\": \"Previous\", \"name\": \"Previous Cycle\"}}]}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the facility's total Consumption volume (i.e. ART Consumption + PMTCT Consumption) in a given cycle is stable relative to that of the previous cycle, with stability defined as a change of less than 50%. This test is run for the system's three Sample Formulations but excludes facilities that are considered \"low volume\", according to the following rules:\r\n\r\n1) For Sample Formulation 1, Adult TDF/3TC/EFV: Total consumption in either cycle must be at least 20 packs\r\n\r\n2) For Sample Formulation 2, Paediatric ABC/3TC: Total consumption in either cycle must be at least 10 packs\r\n\r\n3) For Sample Formulation 3, Paediatric EFV: Total consumption in either cycle must be at least 10 packs\r\n\r\nTo note, in situations where there is a drastic shift in consumption for TDF/3TC/EFV it may be due to a stock-out and the facility has shifted to using TDF/3TC + EFV. This must be checked for manual to determine if this is the underlying reason for the drastic shift in consumption period to period for TDF/3TC/EFV.",
      "short_description": "STABLE CONSUMPTION: Consumption changes by less than 50% vs. previous cycle?",
      "featured": false,
      "slug": "stable-consumption"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 12,
    "fields": {
      "order": 12,
      "name": "WAREHOUSE FULFILMENT",
      "created": "2017-11-27T08:15:31.596Z",
      "last_updated": "2018-04-05T03:58:15.659Z",
      "definition": "{\"operator\": {\"id\": \"AreEqual\", \"name\": \"AreEqual\"}, \"type\": {\"id\": \"FacilityTwoGroupsAndTracingFormulation\"}, \"groups\": [{\"selected_formulations\": [], \"name\": \"G1\", \"selected_fields\": [\"quantity_received\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [], \"name\": \"G2\", \"selected_fields\": [\"packs_ordered\"], \"aggregation\": {\"id\": \"VALUE\", \"name\": \"VALUE\"}, \"model\": {\"hasTrace\": true, \"id\": \"Consumption\", \"tracingFormulations\": [{\"patient_formulations\": [\"TDF/3TC/EFV (PMTCT)\", \"TDF/3TC/EFV (ADULT)\"], \"consumption_formulations\": [\"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"], \"name\": \"TDF/3TC/EFV (Adult)\", \"slug\": \"tdf3tcefv-adult\"}, {\"patient_formulations\": [\"ABC/3TC/LPV/r\", \"ABC/3TC/EFV\", \"ABC/3TC/NVP\"], \"consumption_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"ABC/3TC (Paed)\", \"slug\": \"abc3tc-paed\"}, {\"patient_formulations\": [\"ABC/3TC/EFV\", \"AZT/3TC/EFV\"], \"consumption_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\"], \"name\": \"EFV200 (Paed)\", \"slug\": \"efv200-paed\"}], \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Previous\", \"name\": \"Previous Cycle\"}}]}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the \"Quantity Received\" reported by the facility in one cycle is the same as the \"Packs Ordered\" result of the previous cycle.\r\n\r\nThis test can therefore reflect more than just the facility's ability to input correct figures as per what has been delivered. It also tests warehouse ability to correctly deliver what has been requested",
      "short_description": "WAREHOUSE FULFILMENT: Volume delivered = volume ordered in previous cycle?",
      "featured": false,
      "slug": "warehouse-fulfilment"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 13,
    "fields": {
      "order": 13,
      "name": "NRTI vs. INSTI/NNRTI/PI patient volumes (ADULT)",
      "created": "2017-11-27T08:15:31.596Z",
      "last_updated": "2018-04-05T03:58:15.660Z",
      "definition": "{\"operator\": {\"id\": \"LessThan\", \"name\": \"Percentage Variance is less than\"}, \"operatorConstant\": 30, \"type\": {\"id\": \"FacilityTwoGroups\"}, \"groups\": [{\"selected_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 600mg/300mg [Pack 30]\", \"Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg [Pack 30]\", \"Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg [Pack 60]\"], \"name\": \"G1\", \"factors\": {\"Abacavir/Lamivudine (ABC/3TC) 600mg/300mg [Pack 30]\": \"0.5\", \"Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg [Pack 30]\": \"0.5\", \"Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg [Pack 60]\": \"0.5\"}, \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_factors\": true, \"model\": {\"id\": \"Consumption\", \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [\"Atazanavir/Ritonavir (ATV/r) 300mg/100mg [Pack 30]\", \"Efavirenz (EFV) 600mg [Pack 30]\", \"Lopinavir/Ritonavir (LPV/r) 200mg/50mg [Pack 120]\", \"Nevirapine (NVP) 200mg [Pack 60]\"], \"name\": \"G2\", \"factors\": {\"Nevirapine (NVP) 200mg [Pack 60]\": \"0.5\", \"Atazanavir/Ritonavir (ATV/r) 300mg/100mg [Pack 30]\": \"0.5\", \"Lopinavir/Ritonavir (LPV/r) 200mg/50mg [Pack 120]\": \"0.5\", \"consumption\": 1, \"Efavirenz (EFV) 600mg [Pack 30]\": \"0.5\"}, \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_factors\": true, \"model\": {\"id\": \"Consumption\", \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}]}",
      "description": "Tests if the current patient numbers implied by facility's reported Adult NRTI consumption volumes are similar to those implied by the reported Adult NNRTI/PI consumption volumes\r\n\r\nThis is done by taking total consumption volumes (ART and PMTCT) for each of the formulations below, converting to patient numbers (by dividing through by 2.0 for all formulations), summing the totals for both sets of formulations (NRTI and NNRTI/PI) separately, and finally testing if the two resulting figures are within 30% of each other.\r\n\r\nNRTI formulations: TDF/3TC 300/300mg, AZT/3TC 300/150mg, ABC/3TC 600/300mg\r\nNNRTI/PI formulations: NVP 200mg, EFV 600mg, ATV/r 300/100mg, LPV/r 200/50mg",
      "short_description": "NRTI vs. INSTI/NNRTI/PI patient volumes (ADULT): Differ by <30%?",
      "featured": false,
      "slug": "nrti-vs-insti-nnrti-pi-patient-volumes-adult"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 14,
    "fields": {
      "order": 14,
      "name": "NRTI vs. INSTI/NNRTI/PI Patient Volumes (PAED)",
      "created": "2017-11-27T08:15:31.597Z",
      "last_updated": "2018-04-05T03:58:15.661Z",
      "definition": "{\"operator\": {\"id\": \"LessThan\", \"name\": \"Percentage Variance is less than\"}, \"operatorConstant\": 30, \"type\": {\"id\": \"FacilityTwoGroups\"}, \"groups\": [{\"selected_formulations\": [\"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\", \"Zidovudine/Lamivudine (AZT/3TC) 60mg/30mg [Pack 60]\"], \"name\": \"G1\", \"factors\": {\"Zidovudine/Lamivudine (AZT/3TC) 60mg/30mg [Pack 60]\": \"0.25\", \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\": \"0.5\"}, \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_factors\": true, \"model\": {\"id\": \"Consumption\", \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}, {\"selected_formulations\": [\"Efavirenz (EFV) 200mg [Pack 90]\", \"Lopinavir/Ritonavir (LPV/r) 100mg/25mg\", \"Nevirapine (NVP) 50mg [Pack 60]\", \"Lopinavir/Ritonavir (LPV/r) 40mg/10mg Pellets [Pack of 120]\"], \"name\": \"G2\", \"factors\": {\"Efavirenz (EFV) 200mg [Pack 90]\": \"0.5\", \"Nevirapine (NVP) 50mg [Pack 60]\": \"0.5\", \"consumption\": 1, \"Lopinavir/Ritonavir (LPV/r) 40mg/10mg Pellets [Pack of 120]\": \"0.25\", \"Lopinavir/Ritonavir (LPV/r) 100mg/25mg\": \"0.5\"}, \"selected_fields\": [\"consumption\"], \"aggregation\": {\"id\": \"SUM\", \"name\": \"SUM\"}, \"has_factors\": true, \"model\": {\"id\": \"Consumption\", \"name\": \"Consumption Records\"}, \"cycle\": {\"id\": \"Current\", \"name\": \"Current Cycle\"}}]}",
      "description": "Tests if the current reported Paediatric NRTI patient volumes (implied using consumption volumes) are similar to the reported Paediatric NNRTI/PI patient volumes (implied using consumption volumes).\r\n\r\nThis is done by taking total consumption volumes (ART and PMTCT) for each of the formulations below, converting the consumption values into patient volumes, summing the totals for both sets of formulations (NRTI and NNRTI/PI) separately, and finally testing if the two resulting figures are within 30% of each other.\r\n\r\nNRTI formulations: AZT/3TC 60/30mg, ABC/3TC 120/60mg\r\nNNRTI/PI formulations: NVP 50mg, EFV 200mg, LPV/r 100/25mg, LPV/r 40/10mg",
      "short_description": "NRTI vs. INSTI/NNRTI/PI patient volumes (PAED): Differ by <30%?",
      "featured": false,
      "slug": "nrti-vs-insti-nnrti-pi-patient-volumes-paed"
    }
  },
  {
    "model": "dashboard.facilitytest",
    "pk": 15,
    "fields": {
      "order": 11,
      "name": "STABLE PATIENTS",
      "created": "2018-02-16T18:10:37.716Z",
      "last_updated": "2018-04-08T16:15:25.006Z",
      "definition": "{\r\n  \"operator\": {\r\n    \"id\": \"LessThan\",\r\n    \"name\": \"Percentage Variance is less than\"\r\n  },\r\n  \"operatorConstant\": 50,\r\n  \"type\": {\r\n    \"id\": \"FacilityTwoGroupsAndTracingFormulation\",\r\n    \"name\": \"Facility with 2 Groups And Tracing Formulation\",\r\n    \"comparisons\": [\r\n      {\r\n        \"id\": \"LessThan\",\r\n        \"name\": \"Percentage Variance is less than\"\r\n      },\r\n      {\r\n        \"id\": \"AtLeastNOfTotal\",\r\n        \"name\": \"Group1 Is at least N% of the total\"\r\n      },\r\n      {\r\n        \"id\": \"AreEqual\",\r\n        \"name\": \"Are Equal\"\r\n      },\r\n      {\r\n        \"id\": \"AreNotEqual\",\r\n        \"name\": \"Are Not Equal\"\r\n      },\r\n      {\r\n        \"id\": \"NoNegatives\",\r\n        \"name\": \"Has No Negatives\"\r\n      },\r\n      {\r\n        \"id\": \"NoBlanks\",\r\n        \"name\": \"Has No Blanks\"\r\n      }\r\n    ],\r\n    \"calculations\": [\r\n      {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"Sum\"\r\n      },\r\n      {\r\n        \"id\": \"AVG\",\r\n        \"name\": \"Average\"\r\n      },\r\n      {\r\n        \"id\": \"VALUE\",\r\n        \"name\": \"Values\"\r\n      }\r\n    ],\r\n    \"models\": [\r\n      {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": true,\r\n        \"overrideOptions\": []\r\n      },\r\n      {\r\n        \"id\": \"Paed\",\r\n        \"name\": \"Paed Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationPaed\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/EFV\",\r\n          \"ABC/3TC/LPV/r\",\r\n          \"ABC/3TC/NVP\",\r\n          \"AZT/3TC/ABC\",\r\n          \"AZT/3TC/EFV\",\r\n          \"AZT/3TC/LPV/r\",\r\n          \"AZT/3TC/NVP\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": true,\r\n        \"overrideOptions\": []\r\n      },\r\n      {\r\n        \"id\": \"Consumption\",\r\n        \"name\": \"Consumption Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationConsumption\",\r\n        \"fields\": [\r\n          \"closing_balance\",\r\n          \"consumption\",\r\n          \"days_out_of_stock\",\r\n          \"estimated_number_of_new_patients\",\r\n          \"estimated_number_of_new_pregnant_women\",\r\n          \"loses_adjustments\",\r\n          \"months_of_stock_on_hand\",\r\n          \"opening_balance\",\r\n          \"packs_ordered\",\r\n          \"quantity_received\",\r\n          \"quantity_required_for_current_patients\"\r\n        ],\r\n        \"formulations\": [\r\n          \"Abacavir (ABC) 300mg\",\r\n          \"Abacavir (ABC) 60mg\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 600mg/300mg [Pack 30]\",\r\n          \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Atazanavir/Ritonavir (ATV/r) 300mg/100mg [Pack 30]\",\r\n          \"Cotrimoxazole 120mg [Pack 1000]\",\r\n          \"Cotrimoxazole 960mg[Pack 1000]\",\r\n          \"Dapsone 100mg [Pack 1000]\",\r\n          \"Efavirenz (EFV) 200mg [Pack 90]\",\r\n          \"Efavirenz (EFV) 50mg [Pack 60]\",\r\n          \"Efavirenz (EFV) 600mg [Pack 30]\",\r\n          \"Fluconazole (FL) 200mg [Pack 28]\",\r\n          \"Fluconazole (FL) IV [IV 100ml]\",\r\n          \"Fluconazole (FL) oral solution [Bottle 35ml]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 100mg/25mg\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 200mg/50mg [Pack 120]\",\r\n          \"Lopinavir/Ritonavir (LPV/r) 40mg/10mg Pellets [Pack of 120]\",\r\n          \"Nevirapine (NVP) 10mg/ml oral susp.[Bottle 1000ml]\",\r\n          \"Nevirapine (NVP) 200mg [Pack 60]\",\r\n          \"Nevirapine (NVP) 50mg [Pack 60]\",\r\n          \"Tenofovir/Lamivudine (TDF/3TC) 300mg/300mg [Pack 30]\",\r\n          \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\",\r\n          \"Zidovudine (AZT) 300mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 300mg/150mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine (AZT/3TC) 60mg/30mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 300mg/150mg/200mg [Pack 60]\",\r\n          \"Zidovudine/Lamivudine/Nevirapine (AZT/3TC/NVP) 60mg/30mg/50mg [Pack 60]\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": false,\r\n        \"overrideOptions\": []\r\n      }\r\n    ]\r\n  },\r\n  \"groups\": [\r\n    {\r\n      \"cycles\": [\r\n        {\r\n          \"id\": \"Current\",\r\n          \"name\": \"Current Cycle\"\r\n        }\r\n      ],\r\n      \"cycle\": {\r\n        \"id\": \"Current\",\r\n        \"name\": \"Current Cycle\"\r\n      },\r\n      \"model\": {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": true,\r\n        \"overrideOptions\": []\r\n      },\r\n      \"aggregation\": {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"Sum\"\r\n      },\r\n      \"selected_fields\": [\r\n        \"existing\",\r\n        \"new\"\r\n      ],\r\n      \"selected_formulations\": [],\r\n      \"sample_formulation_model_overridden\": {\r\n        \"abc3tc-paed\": true,\r\n        \"efv200-paed\": true\r\n      },\r\n      \"sample_formulation_model_overrides\": {\r\n        \"abc3tc-paed\": {\r\n          \"id\": \"Paed\",\r\n          \"formulations\": [\r\n            \"ABC/3TC/LPV/r\",\r\n            \"ABC/3TC/EFV\",\r\n            \"ABC/3TC/NVP\"\r\n          ]\r\n        }\r\n      },\r\n      \"name\": \"G1\",\r\n      \"has_thresholds\": true,\r\n      \"thresholds\": {\r\n        \"tdf3tcefv-adult\": \"20\",\r\n        \"abc3tc-paed\": \"10\",\r\n        \"efv200-paed\": \"10\"\r\n      }\r\n    },\r\n    {\r\n      \"cycles\": [\r\n        {\r\n          \"id\": \"Current\",\r\n          \"name\": \"Current Cycle\"\r\n        },\r\n        {\r\n          \"id\": \"Previous\",\r\n          \"name\": \"Previous Cycle\"\r\n        }\r\n      ],\r\n      \"cycle\": {\r\n        \"id\": \"Previous\",\r\n        \"name\": \"Previous Cycle\"\r\n      },\r\n      \"model\": {\r\n        \"id\": \"Adult\",\r\n        \"name\": \"Adult Records\",\r\n        \"selectId\": \"FacilityTwoGroupsAndTracingFormulationAdult\",\r\n        \"fields\": [\r\n          \"existing\",\r\n          \"new\"\r\n        ],\r\n        \"formulations\": [\r\n          \"ABC/3TC/ATV/r (ADULT)\",\r\n          \"ABC/3TC/ATV/r (PMTCT)\",\r\n          \"ABC/3TC/AZT (ADULT)\",\r\n          \"ABC/3TC/AZT (PMTCT)\",\r\n          \"ABC/3TC/EFV (ADULT)\",\r\n          \"ABC/3TC/EFV (PMTCT)\",\r\n          \"ABC/3TC/LPV/r (ADULT)\",\r\n          \"ABC/3TC/LPV/r (PMTCT)\",\r\n          \"ABC/3TC/NVP (ADULT)\",\r\n          \"ABC/3TC/NVP (PMTCT)\",\r\n          \"AZT/3TC/ATV/r (ADULT)\",\r\n          \"AZT/3TC/ATV/r (PMTCT)\",\r\n          \"AZT/3TC/EFV (ADULT)\",\r\n          \"AZT/3TC/EFV (PMTCT)\",\r\n          \"AZT/3TC/LPV/r (ADULT)\",\r\n          \"AZT/3TC/LPV/r (PMTCT)\",\r\n          \"AZT/3TC/NVP (ADULT)\",\r\n          \"AZT/3TC/NVP (PMTCT)\",\r\n          \"TDF/3TC/ATV/r (ADULT)\",\r\n          \"TDF/3TC/ATV/r (PMTCT)\",\r\n          \"TDF/3TC/AZT (ADULT)\",\r\n          \"TDF/3TC/AZT (PMTCT)\",\r\n          \"TDF/3TC/EFV (ADULT)\",\r\n          \"TDF/3TC/EFV (PMTCT)\",\r\n          \"TDF/3TC/LPV/r (ADULT)\",\r\n          \"TDF/3TC/LPV/r (PMTCT)\",\r\n          \"TDF/3TC/NVP (ADULT)\",\r\n          \"TDF/3TC/NVP (PMTCT)\"\r\n        ],\r\n        \"hasTrace\": true,\r\n        \"tracingFormulations\": [\r\n          {\r\n            \"patient_formulations\": [\r\n              \"TDF/3TC/EFV (PMTCT)\",\r\n              \"TDF/3TC/EFV (ADULT)\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Tenofovir/Lamivudine/Efavirenz (TDF/3TC/EFV) 300mg/300mg/600mg[Pack 30]\"\r\n            ],\r\n            \"name\": \"TDF/3TC/EFV (Adult)\",\r\n            \"slug\": \"tdf3tcefv-adult\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/LPV/r\",\r\n              \"ABC/3TC/EFV\",\r\n              \"ABC/3TC/NVP\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Abacavir/Lamivudine (ABC/3TC) 60mg/30mg [Pack 60]\"\r\n            ],\r\n            \"name\": \"ABC/3TC (Paed)\",\r\n            \"slug\": \"abc3tc-paed\"\r\n          },\r\n          {\r\n            \"patient_formulations\": [\r\n              \"ABC/3TC/EFV\",\r\n              \"AZT/3TC/EFV\"\r\n            ],\r\n            \"consumption_formulations\": [\r\n              \"Efavirenz (EFV) 200mg [Pack 90]\"\r\n            ],\r\n            \"name\": \"EFV200 (Paed)\",\r\n            \"slug\": \"efv200-paed\"\r\n          }\r\n        ],\r\n        \"allowOverride\": true,\r\n        \"overrideOptions\": []\r\n      },\r\n      \"aggregation\": {\r\n        \"id\": \"SUM\",\r\n        \"name\": \"Sum\"\r\n      },\r\n      \"selected_fields\": [\r\n        \"existing\",\r\n        \"new\"\r\n      ],\r\n      \"selected_formulations\": [],\r\n      \"sample_formulation_model_overridden\": {\r\n        \"abc3tc-paed\": true,\r\n        \"efv200-paed\": true\r\n      },\r\n      \"sample_formulation_model_overrides\": {\r\n        \"abc3tc-paed\": {\r\n          \"id\": \"Paed\",\r\n          \"formulations\": [\r\n            \"ABC/3TC/LPV/r\",\r\n            \"ABC/3TC/EFV\",\r\n            \"ABC/3TC/NVP\"\r\n          ]\r\n        },\r\n        \"efv200-paed\": {\r\n          \"id\": \"Paed\",\r\n          \"formulations\": [\r\n            \"ABC/3TC/EFV\",\r\n            \"AZT/3TC/EFV\"\r\n          ]\r\n        }\r\n      },\r\n      \"name\": \"G2\",\r\n      \"has_thresholds\": true,\r\n      \"thresholds\": {\r\n        \"tdf3tcefv-adult\": \"20\",\r\n        \"abc3tc-paed\": \"10\",\r\n        \"efv200-paed\": \"10\"\r\n      }\r\n    }\r\n  ]\r\n}",
      "description": "This test is carried out for the system's three Sample Formulations: 1) Adult TDF/3TC/EFV (300/300/600mg), 2) Paediatric ABC/3TC (120/60mg), and 3) Paediatric EFV(200mg)\r\n\r\nTests if the facility's total Patient number (i.e. Existing + New patients) in a given cycle is stable relative to that of the previous cycle, with stability defined as a change of less than 50%. This test is run for the system's three Sample Formulations but excludes facilities that are considered \"low volume\", according to the following rules:\r\n\r\n1) For Sample Formulation 1, Adult TDF/3TC/EFV: Total patients in either cycle on regimen TDF/3TC/EFV must be at least 10\r\n\r\n2) For Sample Formulation 2, Paediatric ABC/3TC: Total paediatric patients in either cycle on regimens ABC/3TC/EFV and ABC/3TC/NVP must be at least 5\r\n\r\n3) For Sample Formulation 3, Efavirenz 200: Total paediatric patients in either cycle on regimens ABC/3TC/EFV and AZT/3TC/EFV must be at least 5",
      "short_description": "Patient volumes change by less than 50% vs. previous cycle?",
      "featured": false,
      "slug": "stable-patients"
    }
  }
]